Hedge fund Shah Capital on Monday
urged Novavax shareholders to vote against re-election
of three directors on the board of the COVID-19 vaccine maker. Shah Capital, which currently owns.
Highlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value .
Hedge fund Shah Capital on Monday
urged Novavax shareholders to vote against the
re-election of three directors and proposals related to
executive compensation, ramping up its efforts for a.